MRNA

Nasdaq

Moderna, Inc.

Health Care, Biotechnology

$59.17

close 7 Aug 2026

+132.31%

52-week change

$23.61B

market cap

$22.28

$85.60

52-week range

Expected price

$22.81 – $27.88

Current price

$59.17

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)-7.41x

P/S (TTM)10.60x

P/B3.49x

EV/EBITDA (TTM)-7.27x

FCF yield (TTM)-5.27%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average13.62x

P/E, sector median29.65x*

Price at 5-year median P/E—*

Forward — analyst consensus

Forward P/E (FY2026)—*

Forward P/E (FY2027)—

Forward PEG—*

Consensus EPS FY2026 (19 analysts)-$8.58

EPS growth (FY2026→FY2027)—

Revenue growth (FY2026)8.31%

Street view

Price target (mean)$50.84*

Target upside-14.07%

Ratings (buy / hold / sell)4 / 16 / 3

FY2026 EPS revisions, 30d (up / down)4 / 2

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

period to 30 Jun 2026, filed 31 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$59.17

Cash & equivalents$1.72B

Total debt$591.00M

Shares outstanding399.00M

Result

DCF price per share-$67.79

Current price$59.17

Margin of safety-214.57%

PV of years 1–10-$10.69B

PV of terminal value-$17.49B

Equity value-$27.05B

Market-implied growth—

The base free cash flow is not positive; growing a negative flow is rarely a meaningful valuation.

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	-$1.31B	-$1.37B	-$1.44B	-$1.51B	-$1.59B	-$1.67B	-$1.75B	-$1.84B	-$1.93B	-$2.03B	-$37.76B
PV	-$1.21B	-$1.18B	-$1.14B	-$1.11B	-$1.08B	-$1.05B	-$1.02B	-$992.99M	-$965.41M	-$938.59M	-$17.49B

period to 30 Jun 2026, filed 31 Jul 2026, close 7 Aug 2026